三七粉口服治疗急性脑出血临床疗效观察

The clinical observation of panax notoginseng powder in treating acute cerebral hemorrhage

目的评价三七粉对急性脑出血治疗的临床疗效。方法将符合诊断的急性脑出血患者分为常规组与治疗组,常规组给予常规治疗,治疗组在急性出血72 h^7 d内在常规治疗的基础上加予口服三七粉。在入组时及治疗14 d后对两组患者分别行神经功能缺损评分,并比较两组患者的临床治疗效果。结果治疗组在临床疗效、神经功能缺损评分改善、脑血肿体积吸收等方面,均明显优于常规组,差异均具有统计学意义(P<0.05)。结论口服三七粉治疗急性脑出血安全有效。

Objective Evaluating the clinical effect of Panax Notoginseng powder in treating acute cerebral hemorrhage. Methods The patients who comform to the diagnosis were divided into the treating group and the regular group. The treating group was given Panax Notoginseng powder on the basis of conventional treatment in acute hemorrhage of 72 h ~ 7 d. The NIHSS of the two were compared when the patients were treated after 14 days. Results In the treatment group, the clinical curative effect, the improvement of the neurological deficit score and the volume absorption of the cerebral hematoma were all superior to the conventional group, the differences were statistically significant(P < 0.05). Conclusion Panax Notoginseng powder was safe and effective in treating acute cerebral hemorrhage.